30
Participants
Start Date
July 15, 2025
Primary Completion Date
December 31, 2025
Study Completion Date
March 31, 2026
Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD)
Participants will be randomly assigned to either an intervention group receiving NSCLD or a control group receiving a sham-intervention treatment. Cognitive function will be assessed using standardized tests before and after the intervention.
sham-intervention treatment
Participants will be randomly assigned to either an intervention group receiving NSCLD or a control group receiving a sham-intervention treatment. Cognitive function will be assessed using standardized tests before and after the intervention.
Tianjin Medical University General Hospital
OTHER
Xuanwu Hospital, Beijing
OTHER
Tao Liu
OTHER